Condition: Pregnancy · Sponsor: ETH Zurich
This study evaluates iron absorption from three antenatal supplements, 30 mg MMS, 60 mg MMS, and 60 mg IFA, in 50 pregnant Kenyan women in their second trimester. Using a randomized crossover design and stable iron isotopes, we will compare bioavailability in both fasted and fed states. Additionally, the trial will investigate if daily dosing triggers a hepcidin response that inhibits subsequent absorption, testing whether alternate-day dosing is a more effective strategy for treating iron deficiency.
This description comes directly from the study's public registry record.
Laura N Wasserfallen, MSc · +41 76 574 88 52 · laura.wasserfallen@pharma.ethz.ch
Always discuss trial participation with your own doctor first.
| Kwale Sub County Hospital | Kwale, Kwale County, Kenya | Recruiting |
| Msambweni County Referral Hospital | Msambweni, Kwale County, Kenya | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07435766